CURRENT
STUDIES
DIABETIC KIDNEY DISEASE
CLINICAL TRIAL
Mercury Clinical Research is seeking volunteers to participate in future medical studies for evaluating the efficacy and safety of an investigational medication in subjects with moderate to advanced diabetic kidney disease.
Be assured that all information is kept strictly confidential per HIPAA regulations, FDA laws, and the American Medical Association ethical guidelines. Compensation may be provided to those that qualify in the study.
This trial is currently pre-screening.
TO QUALIFY
-
At least 18 years of age and no older than 80 years of age
-
Must have a diagnosis of Type 2 Diabetes with an A1C greater than 6%, or proof of active treatment for atleast 6 weeks prior to screening
-
Treatment with an ACEi or ARB at the maximum labeled or tolerated dose deemed appropriate for the subject by the investigator and/or per local SOC for at least 6 weeks prior to enrollment, with a stable dose for at least 2 weeks prior to enrollment
PROVIDED AT NO COST
-
Medical Procedures
-
Physical Examinations
-
Physician Visits
-
Laboratory Tests
-
Medicine
NO INSURANCE NEEDED
If you would like to receive more information about the clinical trial, please, fill out the form below. One of our Research Coordinators will get back to you within 24 hours.
